About us
The Vaccine and Gene Therapy Institute at Oregon Health & Science University has assembled a multidisciplinary team of scientists to respond to serious viral disease threats, including AIDS, chronic viral infection-associated diseases, newly emerging viral diseases and infectious diseases of the elderly. Our programs are intended to span the continuum between basic and clinical science, in which discoveries are rapidly advanced from the level of molecular and cellular biology through animal models and ultimately into clinical testing. Learn more
Upcoming seminars
VGTI Seminar Series and Virology Journal Club is now streamed online. Please reach out to Chad (sixkille@ohsu.edu) if you would like a link to the live stream.

Recent publications
Trends Immunol. Mar 7th, 2023
Programming cytomegalovirus as an HIV vaccine
mBio. Feb 28th, 2023
Virology under the microscope-a call for rational discourse
mBio. Feb 22nd, 2023
Advances in model systems for human Cytomegalovirus latency and reactivation
Nat Commun. Feb 22nd, 2023
Prolonged experimental CD4+ T-cell depletion does not cause disease progression in SIV-infected African green monkeys
Nat Med. Feb 20th, 2023
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation
JCI Insight. Feb 7th, 2023
Late gene expression-deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV
JCI Insight. Jan 23rd, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
Brain Behav Immun. Jan 19th, 2023
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease
Donate to VGTI
Your gifts help provide vital resources to conduct innovative research and more.


COVID-19 Efforts - Building a COVID Testing Lab